Vanguard Group
ESMC

Vanguard Group’s Escalon Medical Corp ESMC Stock Holding History

Vanguard Group’s Portfolio ESMC Stock Details ESMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-59,311
Closed -$40K – 4118
2016
Q3 		$40K Hold
59,311
– – ﹤0.01% 4047
2016
Q2 		$40K Hold
59,311
– – ﹤0.01% 4093
2016
Q1 		$47K Sell
59,311
-29,989
-34% -$27.8K ﹤0.01% 4084
2015
Q4 		$99K Sell
89,300
-16,500
-16% -$18K ﹤0.01% 4082
2015
Q3 		$115K Sell
105,800
-58,756
-36% -$76.2K ﹤0.01% 4077
2015
Q2 		$226K Buy
164,556
+300
+0.2% +$417 ﹤0.01% 4029
2015
Q1 		$222K Hold
164,256
– – ﹤0.01% 3984
2014
Q4 		$264K Hold
164,256
– – ﹤0.01% 3855
2014
Q3 		$261K Hold
164,256
– – ﹤0.01% 3854
2014
Q2 		$281K Hold
164,256
– – ﹤0.01% 3798
2014
Q1 		$253K Buy
164,256
+1,300
+0.8% +$2.29K ﹤0.01% 3784
2013
Q4 		$331K Buy
162,956
+64,798
+66% +$105K ﹤0.01% 3691
2013
Q3 		$145K Buy
98,158
+39,147
+66% +$53K ﹤0.01% 3742
2013
Q2 		$71K Buy
+59,011
New +$70.2K ﹤0.01% 3743

Other funds holding ESMC

WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Vanguard Group's ESMC Position: Q4 2016 in Review

Vanguard Group sold out of Escalon Medical Corp (ESMC) in Q4 2016, closing a stake of 59,311 shares — an estimated $40K sold.

Vanguard Group first reported a position in ESMC in Q2 2013 and held it in 14 quarters. The position peaked at $331K in Q4 2013. 3 funds tracked by Wall St. Rank hold ESMC as of Q4 2016.

  • Vanguard Group reported no remaining Escalon Medical Corp position as of Q4 2016 after selling out during the quarter.
  • Vanguard Group sold 59,311 Escalon Medical Corp shares in Q4 2016, an estimated $40K.
  • Vanguard Group first reported a position in Escalon Medical Corp in Q2 2013 and held it in 14 quarters.
  • Vanguard Group's Escalon Medical Corp position peaked at $331K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Escalon Medical Corp as of Q4 2016.

Based on Vanguard Group's 13F filing for Q4 2016, filed 14 Feb 2017.